Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 10 drugs
Sirolimus, also known as rapamycin, is a macrocyclic lactone antibiotic produced by bacteria Streptomyces hygroscopicus, which was isolated from the soil of the Vai Atari region of Rapa Nui (Easter Island). It was first isolated and identified as an antifungal agent with potent anticandida activity; however, after its potent antitumor...
Approved
Investigational
Matched Description: … bacteria _Streptomyces hygroscopicus_, which was isolated from the soil of the Vai Atari region of Rapa
Brassica rapa pollen is the pollen of the Brassica rapa plant. Brassica rapa pollen is mainly used in allergenic testing.
Approved
Matched Name: … Brassica rapa pollen …
Matched Description: … Brassica rapa pollen is the pollen of the Brassica rapa plant. ... Brassica rapa pollen is mainly used in allergenic testing. …
Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and...
Approved
Rapacuronium was withdrawn in 2001 in many countries due to risk of fatal bronchospasm.
Approved
Withdrawn
RAPA-201 is an autologous rapamycin-resistant T-cell therapy.
Investigational
Matched Name: … RAPA-201 …
Matched Description: … RAPA-201 is an autologous rapamycin-resistant T-cell therapy. …
RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed ex vivo in a process that involves de-differentiation and re-differentiation.
Investigational
Matched Name: … RAPA-501-Allo …
Matched Description: … RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed …
Rapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).
Investigational
Experimental
TRK-001 is an autologous regulatory T-cell therapy. It is being investigated for the prevention of graft rejection following solid organ transplantation.
Investigational
Investigational
Displaying all 10 drugs